Refine by
Disease Information Equipment & Supplies
10 equipment items found
Manufactured by:Augurex Life Sciences Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
14-3-3η is not normally present outside of cells. Therefore, in the disease state, the body views it as foreign and mounts an immune response in an attempt to clear it. This immune response generates14-3-3η specific auto-antibodies that are measureable in blood and provide complementary disease information to the 14-3-3η protein. ...
Manufactured by:BBI Solutions based inCrumlin, UNITED KINGDOM
Shipping Information: Supply of these antibodies is subject to export control restrictions; Abbreviations: Burkholderia; Storage: Store at -20°C, avoid repeat freeze- thaw cycles; Manufacturer Country: UK; Buffer: Phosphate buffered saline pH 7.2; Disease Area: Infectious Disease; Applications: Academic,Elisa, Lateral Flow; Clone Number: ...
Manufactured by:Aelan Cell Technologies based inSan Francisco, CALIFORNIA (USA)
Currently, aging is not defined or descriptive within the clinical ...
Manufactured by:Oxford Gene Technology IP Limited based inOxford, UNITED KINGDOM
The HER2 amplification probe consists of a 347kb probe labelled in red, spanning the HER2 (ERBB2) gene and neighbouring regions, and a green probe for the chromosome 17 ...
Manufactured by:Oxford Gene Technology IP Limited based inOxford, UNITED KINGDOM
The P53 probe mix consists of a 161kb probe, labelled in red that covers the whole P53 (TP53) gene and the flanking regions. The probe mix also contains a control probe for the 17 centromere (D17Z1) that is labelled in ...
Manufactured by:Oxford Gene Technology IP Limited based inOxford, UNITED KINGDOM
The CKS1B/CDKN2C product consists of a 182kb probe, labelled in red, covering the entire CKS1B gene and flanking regions, including the PYGO2 and ZBTB7B genes, and a green probe covering a 170kb region, including the entire CDKN2C gene, the D1S1661 marker and the centromeric end of the FAF1 ...
Manufactured by:Ikarovec based inNorwich, UNITED KINGDOM
Diabetic macular edema (DME) is the most common cause of sight loss in diabetics. The longer you have diabetes, the greater your chance of developing sight loss. About 90% of people with type 1 diabetes will have some degree of retinopathy after 10 years. For people with type 2 diabetes, the chance of developing retinopathy after 10 years is between 67% and 80%. DME is caused by blood vessels in ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Orenitram is a prostacyclin mimetic indicated for treatment of pulmonary arterial hypertension (PAH; WHO Group 1), to delay disease progression and to improve exercise capacity. The studies that established effectiveness included predominately patients with WHO functional class II-III symptoms and etiologies of idiopathic or heritable PAH (66%) or PAH associated with connective tissue disease ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Renasight is a test to determine if there is a genetic cause for an individual’s kidney disease or if there is an increased hereditary risk due to family history. The test uses a blood or saliva sample to test 385 genes associated with chronic kidney disease (CKD). Results are available in approximately 3 ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
TYVASO (treprostinil) is a prostacyclin mimetic indicated for the treatment of: Pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies establishing effectiveness predominately included patients with NYHA Functional Class III symptoms and etiologies of idiopathic or heritable PAH (56%) or PAH associated with connective tissue diseases (33%). The effects diminish ...